DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Pi-Sunyer FX, Aronne LJ, Heshmati HM. et al.
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
JAMA 2006; 295: 761-775
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.